英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

axletree

XDict

n. 轮轴,车轴

PyDict

轮轴,车轴

WordNet (r) 3.0 (2006) (WordNet)

axletree
n 1: a dead axle on a carriage or wagon that has terminal
spindles on which the wheels revolve

The Collaborative International Dictionary of English v.0.48 (gcide)

Axletree \Ax"le*tree`\, n. [Cf. Icel. ["o]xultr?.]
1. A bar or beam of wood or iron, connecting the opposite
wheels of a carriage, on the ends of which the wheels
revolve.
[1913 Webster]

2. A spindle or axle of a wheel. [Obs.]
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
axletree	查看　axletree　在百度字典中的解释	百度英翻中〔查看〕
axletree	查看　axletree　在Google字典中的解释	Google英翻中〔查看〕
axletree	查看　axletree　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://cn.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://cn.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

ELREXFIO REMS | elranatamab-bcmm - Home
ELREXFIO is a B-cell maturation antigen (BCMA)-directed and CD3-directed bispecific antibody indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody
ELREXFIO® (elranatamab-bcmm) Info for Patients | Safety Info
ELREXFIO is a type of treatment called a BCMA -directed bispecific antibody for people with relapsed or refractory multiple myeloma ELREXFIO treats adults with relapsed or refractory multiple myeloma who have already received at least 4 treatment regimens, and their cancer has come back or did not respond to treatment
Treatment Journey | ELREXFIO® (elranatamab-bcmm) For HCPs
Explore the ELREXFIO® (elranatamab-bcmm) treatment journey, including clinical guidance and step-up dosing instructions See risks benefits
Elrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple . . .
ELREXFIO™ (elranatamab-bcmm) is a recently FDA-approved drug for relapsed and refractory multiple myeloma The progression of multiple myeloma involves interactions with various bone marrow cell types, and targeting this microenvironment has shown promising results in inhibiting its growth and osteolysis
Elrexfio Uses, Side Effects, Dosage and more - Drugs. com
Warnings Elrexfio may cause serious side effects, including Cytokine Release Syndrome (CRS) CRS is common during treatment with Elrexfio and can also be serious, life-threatening, or can lead to death Tell your healthcare provider or get medical help right away if you develop any signs or symptoms of CRS, including: fever of 100 4 °F (38 °C) or higher trouble breathing chills dizziness or
ELREXFIO (elranatamab-bcmm) - International Myeloma Foundation
What Is Elrexfio? ELREXFIO® (also known as elranatamab-bcmm, the generic drug name) is a B-cell maturation antigen (BCMA)-CD3-directed bispecific antibody immunotherapy In August 2023, the U S FDA granted accelerated approval of Elrexfio for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy, including a
label - Food and Drug Administration
ELREXFIO is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody
ELREXFIO- elranatamab-bcmm injection, solution - Pfizer
Continue treatment with ELREXFIO until disease progression or unacceptable toxicity Administer pre-treatment medications prior to each dose in the ELREXFIO step-up dosing schedule, which includes step-up dose 1, step-up dose 2, and the first treatment dose as recommended [see Dosage and Administration (2 3)]
Elrexfio (Elranatamab Injection): Side Effects, Uses, Dosage . . .
Elrexfio (Elranatamab Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources
ELREXFIO® (elranatamab-bcmm) for R R Multiple Myeloma | Safety Info
ELREXFIO® (elranatamab-bcmm) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal

中文字典-英文字典 2005-2009